Power gains by using external information in clinical trials are typically not possible when requiring strict type I error control (Q3299104): Difference between revisions
From MaRDI portal
Created a new Item |
Created claim: Wikidata QID (P12): Q91550189, #quickstatements; #temporary_batch_1712272666262 |
||
| (3 intermediate revisions by 3 users not shown) | |||
| Property / MaRDI profile type | |||
| Property / MaRDI profile type: MaRDI publication profile / rank | |||
Normal rank | |||
| Property / full work available at URL | |||
| Property / full work available at URL: https://doi.org/10.1002/bimj.201800395 / rank | |||
Normal rank | |||
| Property / OpenAlex ID | |||
| Property / OpenAlex ID: W2953905579 / rank | |||
Normal rank | |||
| Property / Wikidata QID | |||
| Property / Wikidata QID: Q91550189 / rank | |||
Normal rank | |||
| links / mardi / name | links / mardi / name | ||
Latest revision as of 02:44, 5 April 2024
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Power gains by using external information in clinical trials are typically not possible when requiring strict type I error control |
scientific article |
Statements
Power gains by using external information in clinical trials are typically not possible when requiring strict type I error control (English)
0 references
17 July 2020
0 references
Bayesian dynamic borrowing of information
0 references
evidence synthesis
0 references
frequentist error control
0 references
historical information
0 references
robust prior
0 references
